魅影直播

Skip to main content Skip to footer
魅影直播 Logo
Sign In
Partnerships and Innovation | Vice-Principal Research
Back to linkAbout Vice-Principal Research

Main navigation

  • Home
    • Services for the Queen's Community
    • Policies and Guidelines
    • Services for industry and external partners
    • Scale-up Platform Project
    • Women and non-binary entrepreneurs
    • Supercomputing at Queen's
    • Critical Minerals at Queen's
    • Community Engaged Research at Queen's
    • Current News
    • Learning Hub
    • Our Team
    • Our Office
Back to linkAbout Vice-Principal Research
  1. News
  2. March 4, 2025: U.S. Patent No. 12,239,639 "Cytotoxic Actin-Targeting Compounds"

March 4, 2025: U.S. Patent No. 12,239,639 "Cytotoxic Actin-Targeting Compounds"

Mar 04, 2025

Queen鈥檚 Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,239,639 "Cytotoxic Actin-Targeting Compounds" on March 4, 2025 to Rebecca Grange, John Allingham, Andrew Craig, P. Andrew Evans, and Madhu Aeluri. The patent relates to a class of compounds useful in pharmaceutical compositions and methods for treating or preventing cancer.

U.S. Patent No. 12,239,639 (7 MB, PDF)

Article Category
Faculties and departments
Faculty members
News
Patent
Researchers
魅影直播 logo, linking to the university's homepage

Mailing Addresses

Queen's Partnerships and Innovation
355 King Street West
Kingston, ON K7L 3N6
Canada

Queen's Partnerships and Innovation has a new website
  • Innovation at Queen's has a new website. Visit queensu.ca/innovate
  • Join the Queen's Research Discovery Network.

Proud member of the 

U 15 logo

Web Privacy

Queen鈥檚 University is situated on the territory of the Haudenosaunee and Anishinaabek.

漏 2025 Queen鈥檚 University